Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Read

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Dermatology|September 18, 2010
Baldness reversed by chemotherapyWilliam Read
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Public database of federally funded clinical trials dataWilliam Read
Oncology (Williston Park, N.Y.)|February 3, 2005
Irinotecan and carboplatin in metastatic or recurrent NSCLC: an updateWilliam Read, Howard McLeod, Ramaswamy Govindan
Oncology (Williston Park, N.Y.)|July 31, 2003
Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancerRamaswamy Govindan, William Read, Joan Faust, et al.
World Journal of Clinical Cases|February 17, 2015
Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiationSonal S Noticewala, Loren K Mell, Scott E Olson, et al.
Acta Oncologica (Stockholm, Sweden)|September 27, 2007
A Phase I trial of weekly docetaxel and topotecan for solid tumorsWan Teck Lim, Maria Q Baggstrom, William Read, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2024
Genomic Insights Into High-Grade Infarct-Associated Bone SarcomasTatiana Tvrdik, Sandra Gjorgova Gjeorgjievski, Philip Wong, et al.
Chemotherapy|March 12, 2008
A phase I study of docetaxel and bexaroteneJonathan D Wildi, Maria Q Baggstrom, Rama Suresh, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experienceAruna Kommareddy, Margaret A Coplin, Feng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseRamaswamy Govindan, Nathan Page, Daniel Morgensztern, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|September 18, 2010
Baldness reversed by chemotherapyWilliam Read
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Public database of federally funded clinical trials dataWilliam Read
Oncology (Williston Park, N.Y.)|February 3, 2005
Irinotecan and carboplatin in metastatic or recurrent NSCLC: an updateWilliam Read, Howard McLeod, Ramaswamy Govindan
Oncology (Williston Park, N.Y.)|July 31, 2003
Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancerRamaswamy Govindan, William Read, Joan Faust, et al.
World Journal of Clinical Cases|February 17, 2015
Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiationSonal S Noticewala, Loren K Mell, Scott E Olson, et al.
Acta Oncologica (Stockholm, Sweden)|September 27, 2007
A Phase I trial of weekly docetaxel and topotecan for solid tumorsWan Teck Lim, Maria Q Baggstrom, William Read, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2024
Genomic Insights Into High-Grade Infarct-Associated Bone SarcomasTatiana Tvrdik, Sandra Gjorgova Gjeorgjievski, Philip Wong, et al.
Chemotherapy|March 12, 2008
A phase I study of docetaxel and bexaroteneJonathan D Wildi, Maria Q Baggstrom, Rama Suresh, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experienceAruna Kommareddy, Margaret A Coplin, Feng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results databaseRamaswamy Govindan, Nathan Page, Daniel Morgensztern, et al.
Pageof 2